Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

The OMAGE (Optimization of Medication in AGEd) Transitional Care-Pathway: Impact on Readmissions

Authors not listed

Assistance Publique - Hôpitaux de Paris · 2016

Abstract

Background : The transitional care OMAGE-P combines three best practices recommendations from the French National Authority for Health (HAS) (i) a comprehensive review of diagnosis and treatments (ii) a standardized medical report and (iii)a patient education program specifically designed for older people with multiple chronic conditions and polypharmacy. This transitional care is implemented in a pilot general hospital with the support of French ministry of Health and Regional Agency for Health of Ile de France . The aim of the study is to assess the impact of the OMAGE P transitional care on the readmissions of non demented older people aged 75 years and over within the 3 months following their discharge to home and its cost-effectiveness . Study Population: non demented people aged 75 years and over admitted in emergency (ie via an emergency department ) in the participating units Study design: Observational prospective monocentric non randomized comparative study Exposed patients: eligible patients admitted in participating units and who does not oppose to the collection of his personal data. The hospital physician in charge will conduct the comprehensive review of diagnosis and treatments and will do the standardized medical report. Patient education program will be conduct by the hospital physician and the OMAGE nurse during the hospitalization (two sequences) and during 2 to 4 home visits in the month following patient 's discharge from hospital. Non exposed patients: eligible patients from the usual care arm of the RCT OMAGE. To ensure that risk for emergency readmissions is not different between exposed and non exposed , the rate of emergency readmissions of non exposed group will be compared with the one of eligible patient admitted in the participating units in 2013 and 2014. Setting: General hospital of Eaubonne : geriatric department (acute geriatric unit, rehabilitation unit , geriatric mobile unit ) and internal medicine department Number of subjects to be included: 484 (242 in each arm). The data for the 242 non exposed patients are still available, 242 patients has to be included in the exposed group

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-21 MST

Cite this

APA
Anonymous. (2016). The OMAGE (Optimization of Medication in AGEd) Transitional Care-Pathway: Impact on Readmissions. <em>Assistance Publique - Hôpitaux de Paris</em>. https://clinicaltrials.gov/study/NCT02657642
Vancouver
Anonymous. The OMAGE (Optimization of Medication in AGEd) Transitional Care-Pathway: Impact on Readmissions. Assistance Publique - Hôpitaux de Paris. 2016.
BibTeX
@misc{anon2016TheOMA, title = {The OMAGE (Optimization of Medication in AGEd) Transitional Care-Pathway: Impact on Readmissions}, author = {Anonymous}, journal = {Assistance Publique - Hôpitaux de Paris}, year = {2016}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings